Stay updated on Lanabecestat in Early Alzheimer's Disease Clinical Trial
Sign up to get notified when there's something new on the Lanabecestat in Early Alzheimer's Disease Clinical Trial page.

Latest updates to the Lanabecestat in Early Alzheimer's Disease Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedFooter shows a minor revision update from v3.4.1 to v3.4.2 with no changes to study content, navigation, or data presentation. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check18 days agoChange DetectedAdded Revision: v3.4.1 and removed Revision: v3.4.0. This is a minor version update with no impact on study details or user actions.SummaryDifference0.0%

- Check32 days agoChange DetectedThese changes are minor editorial/UI updates: an additional glossary display option, capitalization tweaks in the QC criteria label, the inclusion of No FEAR Act Data, and a new revision tag (v3.4.0), none of which modify core study content or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check39 days agoChange DetectedA minor update shows Revision: v3.3.4 replacing the previous v3.3.3. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check67 days agoChange DetectedThe page now lists numerous trial locations across the US, Canada, and other countries, expanding the geographic coverage of the study sites.SummaryDifference3%

- Check89 days agoChange DetectedPage revision updated from v3.3.1 to v3.3.2; no user-facing content or layout changes are visible. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Lanabecestat in Early Alzheimer's Disease Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Lanabecestat in Early Alzheimer's Disease Clinical Trial page.